Did a boy’s life-saving gene therapy cause his brain tumour?

AI Insight

A rare case has been documented in which a gene therapy treatment administered to a child for a genetic disorder appears to have caused a brain tumour. Genetic investigation traced the cancer's origin to a virus used as a delivery vector in the therapeutic procedure. This finding highlights a potential oncogenic risk associated with viral vectors employed in gene therapy protocols.

Why it matters

This case raises important safety considerations for the use of viral vectors in gene therapy and may prompt regulatory bodies and researchers to reassess risk monitoring protocols for patients who have received such treatments, particularly children.